13 Cerebrovascular Management in Skull Base Tumors



Anoop P. Patel, Sabareesh K. Natarajan, Basavaraj Ghodke, and Laligam N. Sekhar


Summary


Skull base tumors represent a particular challenge with regard to management of cerebrovascular structures, as they often displace, encase, or invade vital blood vessels during their growth. Surgical management of these tumors requires intimate knowledge of their association with blood vessels as well as of appropriate management strategies. The goal of this chapter is to discuss cerebrovascular management during surgery for skull base tumors with emphasis on understanding patterns of vascular involvement and how such considerations are important for preoperative planning. We also address revascularization for challenging cases, including indications, techniques, and outcomes.




13 Cerebrovascular Management in Skull Base Tumors



13.1 Introduction


Skull base tumors are some of the most challenging lesions for surgeons to deal with. Involvement of critical vascular structures is one of the reasons surgery for these tumors is particularly difficult. Knowledge of vascular management during these operations is important for ensuring optimal patient outcomes while maximizing surgical resection. This chapter focuses on various aspects of vascular management during skull base surgery, including preoperative evaluation and embolization, arterial and venous preservation and reconstruction, management of intraoperative vascular injury, and postoperative management of vasospasm.



13.2 Preoperative Imaging


Typical imaging for skull base tumors includes an MRI, in which T2-weighted sequences are often most useful for delineating the relationship of the tumor to the vasculature. Important things to note on preoperative MRI include degree of encasement or involvement of a vessel (partial vs. circumferential), presence of a cerebrospinal fluid (CSF) or arachnoid plane on T2-weighted imaging, and any evidence of arterial or venous narrowing related to the mass. Postcontrasted images can be useful for looking at the extent of the tumor but in many cases do not allow for distinction between vascular structures and enhancing tumor.


Cerebral angiography is the gold standard for evaluating vascular involvement of skull base tumors. Angiography allows simultaneous visualization of degree of stenosis of arterial or venous structures, collateralization, and evaluation of compensatory flow via balloon test occlusion and compression studies. The relative sizes and contributions of the internal carotid arteries, completeness of the circle of Willis, and comparative size of the vertebral arteries (VA) should all be noted. Variant anatomy (such as atretic segments, fetal configurations, and duplicated arteries) should be clearly visualized and integrated into the surgeon’s vascular management plan.


In cases of internal carotid artery (ICA) encasement, we perform angiography with ipsilateral common carotid artery compression. In a patient in whom surgical occlusion is planned, a carotid compression arteriogram with contralateral carotid and vertebral injection is performed to evaluate collateral flow through the anterior communicating artery (Acom) or the posterior communicating artery (Pcom). This information is used to decide whether the external carotid artery (ECA; no cross flow) or ICA (cross flow present) should be used as the donor artery for bypass, and it gives the surgeon vital information about collateral sources and tolerance for temporary occlusion during bypass or reconstruction.


Venous phase angiography is a must for any tumors that involve or are adjacent to the large venous outflow structures, such as the torcula, transverse and sigmoid sinuses, vein of Labbé, and straight sinus. The size and dominance of the transverse or sigmoid sinus and collateralization through the torcula can alter the surgical approach by revealing a very large sigmoid sinus or high-riding jugular bulb, either of which can significantly affect the amount of exposure. If there is complete occlusion and collateralization of venous drainage, this typically means that the venous structure can be sacrificed in the region adjacent to the tumor. If there is flow through a major venous channel with little evidence of collateralization, effort should be made to preserve this so as to prevent venous hypertension and infarct postoperatively. This can be accomplished either by leaving tumor behind or by aggressive resection and venous reconstruction.


Configuration, relative sizes, and anastomotic relationships of the veins draining the temporal lobe are particularly important. In most patients, the veins of Labbé and the superficial middle cerebral veins have an inverse relationship. The most common configuration is one in which they are relatively equal in size, but in some cases a particularly large vein of Labbé is accompanied by small middle cerebral veins, or vice versa. The consequences of occluding a large or dominant vein must be factored into surgical planning to avoid venous infarction. Knowledge of Labbé drainage is particularly important for subtemporal and presigmoid approaches, for opening the dura along the floor of the temporal fossa can compromise the vein of Labbé if its location is not known preoperatively.1 ,​ 2 ,​ 3 ,​ 4


As a result, preoperative angiography is critically important for understanding both arterial and venous relationships during skull base surgery. In situations in which angiography is not available or is contraindicated, CT or MRI angiography and/or venography can provide useful adjunctive information but rarely replaces the value of a complete cerebral angiogram.



13.3 Preoperative Embolization


Preoperative angiography also provides an opportunity for embolization. It is our practice to attempt embolization for all cranial base meningiomas so as to reduce blood loss and operative time, as has been reported in prior studies.5 ,​ 6 ,​ 7 Decreasing vascularity to the tumor has the dual advantage of improving visualization during resection and, in some cases, causing the tumor to necrose and soften, allowing for easier removal and decreasing the forces transmitted to adjacent neural structures.


The arteries commonly embolized include the meningohypophyseal branch of the ICA; the branches of the ECA—the sphenopalatine artery, middle meningeal artery, accessory meningeal artery, internal maxillary artery, ascending pharyngeal artery, and others; and, rarely, the meningeal branches of the VA.


Tumor embolization is performed under local (ECA branches) or general (ICA branches) anesthesia. To facilitate the selective catheterization of the small branches, a Renegade (Boston Scientific; for larger pedicles, such as ascending pharyngeal artery) or Marathon (ev3; for smaller pedicles, such as meningohypophyseal trunk) microcatheter is used. A manual injection of undiluted, nonionic contrast agent is performed with a 1.0 mL syringe, very slowly until the contrast agent becomes visible, after which the rate of injection is increased slowly. If tumor vascularity is apparent, the injection is repeated, with the rate of injection increased to possibly identify reflux into the carotid siphon. Filming is biplane so as to evaluate potential cross-filling of contralateral branches. An idea of the force required to cause reflux into cerebral arteries is thus obtained prior to the embolization procedure.


Embolization is ideally performed 3 to 7 days before the planned procedure. The goal of embolization is to permeate the interstices of the tumor with particles, occluding the feeding arteries at the very end if they are large. Embolization material consists of particles of polyvinyl acetyl foam (PVA) suspended in undiluted, nonionic contrast agent, injected slowly. The size of the particle used depends on the potential for reflux and supply to cranial nerves (CNs) from the pedicle being embolized. The average size of the particles used for embolization is 150 to 250 μm, with larger particles 250 to 400 μm being used for the embolization of the ascending pharyngeal artery to avoid occlusion of branches feeding CNs X and XI. Additionally, small Gelfoam pledgets are used to block arteries at the end of the procedure. In hypervascular tumors, liquid embolic agents such as Onyx, n-BCA, or coils are used for flow reduction.


The risks of embolization, including skin necrosis, CN dysfunction, stroke, and blindness, should be weighed against the perioperative and postoperative advantages. Embolization of some large or giant tumors may result in tumor swelling, which may precipitate emergent surgery.



13.4 Management of Arterial Encasement


Intracranial skull base tumors frequently encase the basal arteries, ICA, VA, basilar artery (BA), and their branches. Most tumors that encase vessels in the subarachnoid segment of the artery respect the arachnoid planes around the tumor and vessel. As a result, they can often be dissected away safely after adequate debulking. The most important factors that determine whether a tumor will be resectable from around a vessel are presence of perforators, evidence of vessel narrowing (indicating vessel invasion), and overall consistency of the tumor.8 The arachnoid planes are typically absent in cases of prior surgery or radiotherapy, rendering this dissection less feasible; arterial or venous injury is much more common in such cases. Extradural involvement of an artery can also be managed by microdissection of the tumor from the artery or vein if the pathology involved is benign. For example, schwannomas, cavernous hemangiomas, and benign meningiomas are almost always amenable to dissection. Instances of recurrent or higher-grade meningiomas or more malignant pathology (head and neck malignancy, sarcomas, adenoid cystic carcinoma) in which the arterial wall is invaded and the artery is narrowed represent situations in which intraoperative injury would be likely if dissection were attempted.


Management of these situations should be taken on a case-by-case basis. If the pathology in question can be treated using adjuvant chemotherapy or radiation, the management strategy will typically involve leaving tumor behind on the vessel and treatment with adjuvant techniques. However, when alternative therapies have been exhausted (recurrences) or the pathology is by nature highly malignant (e.g., adenoid cystic carcinoma), vascular sacrifice and aggressive resection should be considered with or without reconstruction or bypass, depending on the situation. Although the use of bypasses for skull base tumors has declined in frequency owing to advances in adjuvant treatment techniques, bypass and primary reconstruction techniques remain valuable tools in the management of skull base tumors such as recurrent meningiomas, recurrent chordomas, chondrosarcomas, and other malignant tumors.9 ,​ 10 ,​ 11 ,​ 12 ,​ 13



13.4.1 Operative Technique in a Tumor with Subarachnoid Encasement


Proximal control of the exposed artery is obtained, followed by exposure of the tumor while minimizing brain retraction and then distal exposure of the artery beyond the encasement. The artery is then traced through the tumor from both sides, with frequent debulking. Suction, bipolar cautery, fine dissectors, and microscissors are used for dissection of the artery. In case of an artery that has multiple perforators, the surface without perforators is dissected first, followed by the portion containing perforating branches.



13.4.2 Decision to Bypass in Cases of Vascular Occlusion or Sacrifice


The need for bypass in cases in which sacrifice of the ICA or VA is planned is somewhat controversial and depends on many patient-specific factors. Information obtained from preoperative balloon occlusion tests, coupled with monitoring of cerebral blood flow by single photon emission computed tomography (SPECT), transcranial dopplers (TCD), or angiography, can provide insights into whether a vessel can be sacrificed without the need for bypass. The success of this selective bypass approach depends on the accuracy of preoperative testing.


Based on a review of a series of patients operated on by the senior author (LNS) who were not revascularized and who suffered strokes, as well as the reports of other surgeons who had similar experiences,14 ,​ 15 ,​ 16 ,​ s. Literatur we currently practice a universal bypass approach if the ICA must be occluded for tumor cases. For posterior circulation, bypass is not necessary for a markedly nondominant VA. However, if the VA is equal or dominant, we do perform a reconstruction or bypass. The BA should always be reconstructed if injured, although patients can tolerate distal basilar occlusion if there is significant PCom flow. In the event of unexpected intraoperative injury to major arteries, it is best to reconstruct the vessel using either a local, regional, or extraintracranial bypass technique, because the adequacy of collateral circulation cannot be determined.


Indications for bypass in the modern era of skull base surgery can be summarized as follows18:




  • Benign tumor encasing a major artery and the tumor cannot be dissected free for complete resection without damaging the artery. Bypass is typically pursued with recurrent and previously radiated benign tumors. As an alternative, a small amount of tumor can be left behind and re-irradiated if allowable.



  • Malignant tumor involving a major artery: complete resection is the goal set preoperatively based on the principles of oncologic treatment, whereby negative margins are imperative for optimal tumor control.



  • A major artery already occluded by the tumor and the patient is having ischemic symptoms, or there is preoperative evidence of significantly reduced cerebrovascular reserve.



  • Unplanned intraoperative injury to a major artery that cannot be directly repaired or sutured.



13.4.3 Choice of Bypass Grafts


Bypasses may be divided into two groups: replacement bypasses (e.g., radial artery graft [RAG]/saphenous vein graft [SVG] to replace the ICA/VA) and augmentation bypasses (e.g., STA–MCA bypass performed in a patient who has brain ischemia secondary to ICA occlusion, or occipital artery [OA] to posteroinferior cerebellar artery [PICA] for a patient who has VA occlusion). Most of the bypasses performed for skull base tumors are replacement bypasses using RAG, SVG, or rarely, the superficial temporal artery (STA). Local repair of an injured artery may also be performed in some cases.


The radial artery provides flow rates between 50 and 150 mL/minute acutely, and flow can increase significantly over the ensuing days, as measured by duplex ultrasound.19 We perform preoperative mapping of the arterial tree of the arm as well as an Allen’s test to ensure adequate collateral perfusion. Although the radial artery is easier to harvest than the saphenous vein is, postoperative vasospasm in RAG is an important concern but has been largely alleviated by use of the pressure distention technique, which significantly lowers rates of postoperative vasospasm in arterial grafts.9 ,​ 20 ,​ 21


SVGs are an alternative to RAG for high-flow replacement bypasses. We use the saphenous vein when the radial artery is smaller than 1.5 mm or is unavailable for any reason (e.g., prior harvest, insufficiency of palmar arch). In children younger than 12, the radial artery is typically too small, mandating the use of SVG if needed. Flow rates in SVGs are typically higher than in RAGs, in the range of 100 to 250 mL/minute.19 These high flow rates can cause flow mismatches and/or hyperperfusion syndromes when anastomosed to the middle cerebral artery (MCA) or posterior cerebral artery (PCA). Moreover, vein grafts are more technically challenging to anastomose and can be prone to kinking. Accordingly, a RAG that has been pressure-distended to decrease postoperative vasospasm is our graft conduit of choice.



13.4.4 Anesthesia, Monitoring, and Preparation


When a bypass may be needed, preoperative duplex imaging of the radial arteries and saphenous veins and an Allen’s test are performed to facilitate graft selection based on the parameters already outlined (Fig. 13.1). We also monitor pulse oximetry intraoperatively to ensure adequate perfusion of the hand after temporary occlusion of the radial artery prior to harvest. The patient is given 325 mg of aspirin preoperatively. Intraoperative monitoring of electroencephalogram, somatosensory evoked potentials, and motor evoked potentials is employed. Total intravenous anesthesia is used to allow monitoring of motor evoked potentials. If a bypass is performed, the anesthesiologist is asked to raise the patient’s mean arterial pressure by about 20% during temporary occlusion to facilitate collateral perfusion and then places the patient in burst suppression with propofol for brain protection. Approximately 3,000 to 5,000 units of heparin are also administered just prior to vascular occlusion. We do not reverse heparinization at the end of the procedure. Meticulous hemostasis is required prior to heparin dosing to prevent bleeding that can obscure the operative field.

Fig. 13.1 The Allen’s test for evaluating patency of the palmar arch prior to harvesting radial artery.


13.4.5 High-Flow (Replacement) Bypass Technique


High-flow bypass techniques are important when major arteries (ICA, dominant VA) must be sacrificed during tumor resection. Replacement of 100 to 250 mL/minute of blood flow can be accomplished using this technique. For a tumor involving the ICA, an ECA or cervical ICA to MCA–M2 segment bypass is preferred (Fig. 13.2). If the MCA vessels are particularly small, the supraclinoid ICA may be used as a recipient vessel. If the proximal ECA or ICA is unavailable for bypass because of tumor involvement, then the V2–V3 segment of the VA can be used as a proximal anastomosis site (Fig. 13.3).

Fig. 13.2 Cervical internal carotid artery (ICA) to supraclinoid ICA bypass.
Fig. 13.3 V3 segment vertebral artery to supraclinoid internal carotid artery bypass.

The cervical ICA is exposed in the neck. The tumor is exposed after a craniotomy and an orbital or orbitozygomatic osteotomy. Our practice is to inspect the tumor and determine whether bypass will be needed—a judgment that sometimes requires removal of some of the tumor along the vessel to determine whether the plane is favorable. When there is no clear plane or when vascular invasion is evident, we proceed with bypass prior to aggressive resection of the tumor.


Accordingly, the radial artery (the entire artery from the brachial artery bifurcation to the anterior wrist) or the saphenous vein (in the upper leg and lower thigh) is removed, flushed with heparinized saline, and distended under pressure to relieve vasospasm. The distal anastomosis is performed first, to the MCA (M1 bifurcation or M2 segment) or to the supraclinoid ICA. This is followed by the proximal anastomosis to the ECA (if collateral circulation is poor) or to the ICA (if some collaterals are present). If flow through the grafts is satisfactory as assessed by Doppler/intraoperative angiography, then the ICA is trapped between the cervical and supraclinoid segment, proximal to the bypass. The operation is stopped at this stage and a postoperative angiogram obtained to ensure patency of the bypass.


For VA replacement, an extreme lateral retrocondylar or partial transcondylar approach is used. Proximal anastomosis to the VA is done in the V3 segment extradurally, most commonly as the VA traverses the sulcus arteriosus of C1 and prior to the dural entry point. If the distal anastomosis is distal to the PICA, then the PICA may be reimplanted or a PICA-to-PICA anastomosis performed. Alternatively, the PICA may be occluded if there is good collateral flow from the distal vessel. For BA injury, VA or ECA to PCA–P2 segment bypass is performed using RAG or SVG. A temporal craniotomy with a zygomatic osteotomy or a petrosal approach is used to expose the PCA.



13.4.6 Low-/Moderate-Flow (Augmentation) Bypass Techniques


When the patient has some compensatory flow from collateral circulation, a flow-augmenting bypass such as an STA–MCA may be used to add 25 to 100 mL/minute of perfusion. In the posterior circulation, this can be accomplished using an OA–PICA bypass. The more common technique of STA–MCA bypass is discussed here.


The STA is exposed by a direct cut-down technique. The course of the vessel is traced by Doppler ultrasound or frameless neuronavigation and marked on the scalp. Working under the operating microscope, dissection is started distally and the vessel traced proximally. A small cuff of connective tissue is left around the artery. The vessel is left in situ until the bypass procedure. A T-incision is created from the skin incision made to expose the artery so as to facilitate muscle dissection and a small pterional craniotomy. A middle cerebral branch in the distal sylvian fissure (M3 branch), the largest temporal or parietal cortical branch relatively free of perforators, is used for anastomosis. Ideally the recipient vessel should be at least 1.5 mm in diameter, but it can be as narrow as 1.0 mm. The recipient vessel is dissected free of its arachnoidal covering, and a small rubber dam is placed under the artery. The STA is divided, and an oblique arteriotomy and slight fish-mouthing of the STA is done (Fig. 13.4a). Anastomosis to the MCA is done using diametrically opposing sutures at the ends and either running or interrupted 9–0 or 10–0 nylon sutures (Fig. 13.4b,c,d,e). Prior to the tying of the last suture, the lumen is flushed with heparinized saline and the suture tightened. Flow through the STA is checked using a Doppler probe.

Fig. 13.4 (a) The superficial temporal artery is fish-mouthed to enlarge the opening and compensate for size mismatch prior to end-to-side anastomosis. (b,c) Terminal stitches are placed at the heel and the diametrically opposite end of the anastomosis. (d) One side is anastomosed with continuous sutures and (e) the opposite side with interrupted sutures.


13.4.7 Staged Operations


Our typical practice is to stage operations in which a bypass is needed. Craniotomy, exposure osteotomies, and bypass are done during the first surgery, followed by tumor resection 3 to 7 days later. This delay allows some degree of hemodynamic equilibrium and graft maturity after bypass is performed and allows the tumor resection to be done after heparinization has worn off. In addition, tumor resection and skull base repair can be lengthy. The tumor resection and the skull base repair are lengthy and to couple them after the exposure, osteotomy and bypass would make a longer procedure.



13.4.8 Postoperative Management


Postoperative monitoring of graft patency is usually done by Doppler evaluation. An angiogram is performed in the immediate postoperative period or within 24 hours of surgery. If this is not possible, a CT angiogram is obtained to ensure graft patency. Patients are maintained on 325 mg of aspirin. Patients who have SVG are maintained on subcutaneous heparin, 5,000 U every 8 hours for 3 days, in addition to aspirin. Duplex ultrasound studies are performed to follow the volume flow through the graft. The systolic blood pressure should be maintained below 140 mm Hg for 2 to 3 days.


Graft occlusion is most common at the time of surgery or within 24 hours of surgery. If occlusion is noted intraoperatively, it is corrected as needed. Typically the anastomotic sites at the proximal and distal end are examined for thrombus and are reexplored to resolve any kinking or flow-related stasis in the vessel. Further heparinization can be employed if clot continues to form despite good flow. If the graft occludes in the postoperative period, the patient is typically taken back to the operating room for reexploration. Our general practice is not to employ endovascular thrombolysis in these cases, because some mechanical reason for thrombus formation typically needs to be dealt with to ensure long-term patency. Vasospasm occurs occasionally with RAG (despite use of the intraoperative pressure distention technique) and can be successfully treated by endovascular angioplasty or administration of intra-arterial vasodilators such as nicardipine. Following discharge (7–10 days), patients are kept on aspirin for life in case of vein graft and for at least 1 year in cases of RAG. We typically obtain duplex flow measurements and CT angiogram or MR angiogram at 3 months, 1 year, and then subsequently every 1 to 2 years, depending on the situation.



13.4.9 Results


From 1988 to 2006, 130 patients underwent bypasses for tumors (79 for skull base meningiomas, 7 for chondrosarcomas, 7 for chordomas, and 5 for adenoid cystic carcinomas, in addition to other tumors such osteogenic sarcoma, schwannoma, hemangiomas, and hemangiopericytomas; Table 13.1). The immediate patency rate for bypasses was 95.4%, and gross total resection was achieved in 82 (63%) patients, with 29 RAGs and 101 SVGs used. Two patients had delayed graft occlusions (after 2 years), which were revised. Sixteen patients had disease progression or recurrence and died. One patient, who was wheelchair-bound and had multiple lower CN palsies, died 8 months after surgery. One patient had a major stroke despite functioning of the graft and died after 7 days.



































































Table 13.1 Revascularization for tumors 1988–2006

Number of patients


130




  • Meningiomas


79




  • Chondrosarcoma


7




  • Chordoma


7




  • Adenoid cystic carcinoma


5




  • Miscellaneous


32


Type of graft

 



  • Radial artery graft


29




  • Saphenous vein graft


101


Extent of resection

 



  • Gross total resection


82 (63%)




  • Incomplete resection


48 (37%)


Graft patency

 



  • Immediate patency rate


124/130 (95.4%)




  • Delayed graft occlusion


2 (managed by revision, patent at follow-up)


Mortality

 



  • Due to surgery


2/130 (1.5%)




  • Major stroke despite patent graft


1




  • Preoperative deficits and morbidity after surgery


1




  • Due to disease progression/recurrence


17/130 (13.1%)


As already noted, modern practice patterns have led to a decrease in the number of tumors treated using aggressive resection and bypass. The senior author examined his modern series of 20 bypasses in 18 patients operated on for skull base tumors between 2003 and 2012.18 Mean age was 41 years, with 14 anterior circulation bypasses and 4 posterior circulation bypasses. Long-term patency was 100%, although one patient did require a revision of the graft after stenosis was found on surveillance imaging. Seventy-seven percent of patients had had prior treatment, whether surgery or radiation therapy. In this series of largely recurrent or radiated tumors, gross total resection (GTR) was possible in 72% of patients. Long-term outcomes were good for 14 of the patients (mRS < 2), with a mean follow-up of 47 months. One patient died during the perioperative period from complications related to aspiration pneumonia. Of the five patients operated on for malignant disease involving a major artery, three died from progression of their disease (osteosarcoma, synovial sarcoma, chordoma). Similarly poor long-term survival results with highly malignant head and neck disease have been reported by other authors.22 Accordingly, bypass and aggressive resection in cases of highly malignant disease should be considered on a case-by-case basis.


Treatment of the majority of benign lesions or recurrent/higher-grade meningiomas resulted in excellent long-term outcomes. These results have been borne out in several smaller case series of skull base lesions from other institutions.23 ,​ 24 ,​ 25 Accordingly, bypass for the management of complex skull base tumors involving major vessels can be beneficial with good patient selection and surgical technique that minimizes morbidity.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Feb 8, 2021 | Posted by in NEUROSURGERY | Comments Off on 13 Cerebrovascular Management in Skull Base Tumors

Full access? Get Clinical Tree

Get Clinical Tree app for offline access